Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Evrard SM"'
Autor:
David M. Smadja, Clément d’Audigier, Anne-Marie Fischer, Laetitia Mauge, Evrard Sm, Jason C. Kovacic, Dominique Israel-Biet, Pascale Gaussem, Coralie L. Guerin, Ivan Bièche
Publikováno v:
Journal of Thrombosis and Haemostasis. 10:670-679
Summary. Background: Transforming growth factor-β1 (TGF-β1) is a profibrotic cytokine that plays a major role in vascular biology, and is known to regulate the phenotype and activity of various vascular cell populations. Because most fibrotic disea
Autor:
Deshors P; Institut Claudius Regaud, IUCT Oncopole, 31059 Toulouse, France., Arnauduc F; Faculty of Medicine, Paul Sabatier University, Toulouse-3, 31062 Toulouse, France.; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31100 Toulouse, France., Boëlle B; Institut Claudius Regaud, IUCT Oncopole, 31059 Toulouse, France., Cohen-Jonathan Moyal E; Institut Claudius Regaud, IUCT Oncopole, 31059 Toulouse, France.; Faculty of Medicine, Paul Sabatier University, Toulouse-3, 31062 Toulouse, France.; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31100 Toulouse, France., Courtade-Saïdi M; Faculty of Medicine, Paul Sabatier University, Toulouse-3, 31062 Toulouse, France.; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31100 Toulouse, France.; Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole, 31059 Toulouse, France., Evrard SM; Faculty of Medicine, Paul Sabatier University, Toulouse-3, 31062 Toulouse, France.; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31100 Toulouse, France.; Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole, 31059 Toulouse, France.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Mar 18; Vol. 14 (6). Date of Electronic Publication: 2022 Mar 18.
Autor:
Syrykh C; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France., Gorez P; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France., Péricart S; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France., Grand D; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France., Escudié F; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France., Cabarrou B; Biostatistics Department, Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Obéric L; Hematology Department, Institut Universitaire du Cancer-Oncopole, Toulouse, France; and., Ysebaert L; Hematology Department, Institut Universitaire du Cancer-Oncopole, Toulouse, France; and.; Institut National de la Santé et de la Recherche Médicale UMR1037, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse III Paul-Sabatier, Toulouse, France., Lamant L; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France., Laurent C; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France.; Institut National de la Santé et de la Recherche Médicale UMR1037, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse III Paul-Sabatier, Toulouse, France., Evrard SM; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France.; Institut National de la Santé et de la Recherche Médicale UMR1037, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse III Paul-Sabatier, Toulouse, France., Brousset P; Pathology Department, Institut Universitaire du Cancer-Oncopole, CHU Toulouse, Labex TOUCAN, Toulouse, France.; Institut National de la Santé et de la Recherche Médicale UMR1037, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse III Paul-Sabatier, Toulouse, France.
Publikováno v:
Blood advances [Blood Adv] 2021 Nov 23; Vol. 5 (22), pp. 4590-4593.
Autor:
Salvator H; Service de Pneumologie, Hôpital Foch, Suresnes, France; Laboratoire de Recherche en Pharmacologie Respiratoire, Virologie et Immunologie Moleculaire (VIM) Suresnes, V2I - UMR-0892, Suresnes, France; the Faculté Simone Veil des Sciences de la Santé Université Paris-Saclay, Suresnes, France; Faculté Simone Veil des Sciences de la Santé Université Paris-Saclay, Montigny-le-Bretonneux, France. Electronic address: h.salvator@hopital-foch.com., Tcherakian C; Service de Pneumologie, Hôpital Foch, Suresnes, France., Maillard N; Service d'Hématologie, CHU de Poitiers, France., Milin S; d'Anatomopathologie, CHU de Poitiers, France., Bergeron A; Service de Pneumologie, Hopital Saint Louis, APHP, France and Université de Paris, France., Bondeelle L; Service de Pneumologie, Hopital Saint Louis, APHP, France and Université de Paris, France., Meignin V; Service d'Anatomopathologie, Hopital Saint Louis, APHP, France and Université de Paris, France., Nguyen S; Service d'Hématologie, Hôpital Pitié-Salpétrière, APHP Paris, France and Sorbonne Université Paris, France; Société Francophone de Greffe de Moelle et Thérapie Cellulaire., Souchet L; Service d'Hématologie, Hôpital Pitié-Salpétrière, APHP Paris, France and Sorbonne Université Paris, France., Guenounou S; Service d'Hématologie, Institut universitaire du Cancer de Toulouse-Oncopole, CHU Toulouse, Toulouse, France., Evrard SM; Département d'Anatomie et Cytologie pathologiques, Institut universitaire du Cancer de Toulouse-Oncopole, CHU Toulouse, Toulouse, France., Rubio MT; Service d'Hématologie, CHRU Nancy Hôpital Brabois, Vandoeuvre les Nancy, France; Société Francophone de Greffe de Moelle et Thérapie Cellulaire., Robin M; Société Francophone de Greffe de Moelle et Thérapie Cellulaire., Sestili S; Service d'Hématologie et thérapie cellulaire, Hôpital Saint Antoine, APHP and Sorbonne Université Paris, France., Brissot E; Service d'Hématologie et thérapie cellulaire, Hôpital Saint Antoine, APHP and Sorbonne Université Paris, France; INSERM CRSA UMR_S 938, Sorbonne Université Paris, France., Fajac A; Service d'Anatomopathologie, Hôpital Tenon, APHP, Paris, France., Catherinot E; Service de Pneumologie, Hôpital Foch, Suresnes, France., Givel C; Service de Pneumologie, Hôpital Foch, Suresnes, France., Chabrol A; Service de Pneumologie, Hôpital Foch, Suresnes, France., Goyard C; Service de Pneumologie, Hôpital Foch, Suresnes, France., Longchampt E; Service d'Anatomopathologie, Hôpital Foch, Suresnes, France., Chabi-Charvillat ML; Service de Radiologie, Hôpital Foch, Suresnes, France., Bernaudin JF; Sorbonne Université Paris and INSERM UMR 1272, Université Sorbonne Paris Nord and the Sorbonne Université, France., Couderc LJ; Service de Pneumologie, Hôpital Foch, Suresnes, France; Laboratoire de Recherche en Pharmacologie Respiratoire, Virologie et Immunologie Moleculaire (VIM) Suresnes, V2I - UMR-0892, Suresnes, France; the Faculté Simone Veil des Sciences de la Santé Université Paris-Saclay, Suresnes, France; Faculté Simone Veil des Sciences de la Santé Université Paris-Saclay, Montigny-le-Bretonneux, France.
Publikováno v:
Chest [Chest] 2021 Nov; Vol. 160 (5), pp. 1783-1788. Date of Electronic Publication: 2021 Jun 05.
Autor:
Syrykh C; Department of Pathology, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France., Ysebaert L; INSERM UMR1037 Cancer Research Center of Toulouse (CRCT), ERL 5294 National Center for Scientific Research (CNRS), University of Toulouse III Paul-Sabatier, Toulouse, France.; Departement of Hematology, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, Toulouse, France.; Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France.; Institut Carnot Lymphome CALYM, Laboratoire d'Excellence 'TOUCAN', Toulouse, France., Péricart S; Department of Pathology, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France., Evrard SM; Department of Pathology, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; INSERM UMR1037 Cancer Research Center of Toulouse (CRCT), ERL 5294 National Center for Scientific Research (CNRS), University of Toulouse III Paul-Sabatier, Toulouse, France., Meggetto F; INSERM UMR1037 Cancer Research Center of Toulouse (CRCT), ERL 5294 National Center for Scientific Research (CNRS), University of Toulouse III Paul-Sabatier, Toulouse, France.; Institut Carnot Lymphome CALYM, Laboratoire d'Excellence 'TOUCAN', Toulouse, France., Kanoun S; Department of Nuclear Medicine, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, Toulouse, France., Brousset P; Department of Pathology, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; INSERM UMR1037 Cancer Research Center of Toulouse (CRCT), ERL 5294 National Center for Scientific Research (CNRS), University of Toulouse III Paul-Sabatier, Toulouse, France.; Institut Carnot Lymphome CALYM, Laboratoire d'Excellence 'TOUCAN', Toulouse, France., Laurent C; Department of Pathology, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France. laurent.c@chu-toulouse.fr.; INSERM UMR1037 Cancer Research Center of Toulouse (CRCT), ERL 5294 National Center for Scientific Research (CNRS), University of Toulouse III Paul-Sabatier, Toulouse, France. laurent.c@chu-toulouse.fr.; Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France. laurent.c@chu-toulouse.fr.; Institut Carnot Lymphome CALYM, Laboratoire d'Excellence 'TOUCAN', Toulouse, France. laurent.c@chu-toulouse.fr.
Publikováno v:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 Apr; Vol. 478 (4), pp. 779-783. Date of Electronic Publication: 2020 Oct 03.
Autor:
Fabry V; Department of Neurology, Toulouse University Hospital, Toulouse, France.; University of Toulouse III Paul Sabatier, Toulouse, France., Gerdelat A; Neurology, Clinique des Cèdres, Toulouse, France., Acket B; Department of Neurology, Toulouse University Hospital, Toulouse, France., Cintas P; Department of Neurology, Toulouse University Hospital, Toulouse, France., Rousseau V; MeDatAS Unit, Department of Medical and Clinical Pharmacology, Toulouse University Hospital, Toulouse, France., Uro-Coste E; University of Toulouse III Paul Sabatier, Toulouse, France.; Department of Pathology, Toulouse University Hospital, IUC-Oncopole, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France., Evrard SM; University of Toulouse III Paul Sabatier, Toulouse, France.; Department of Pathology, Toulouse University Hospital, IUC-Oncopole, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France., Pavy-Le Traon A; Department of Neurology, Toulouse University Hospital, Toulouse, France.; University of Toulouse III Paul Sabatier, Toulouse, France.; Institute of Cardiovascular and Metabolic Diseases (I2MCUMR1048), Toulouse, France.
Publikováno v:
Frontiers in neurology [Front Neurol] 2020 May 05; Vol. 11, pp. 342. Date of Electronic Publication: 2020 May 05 (Print Publication: 2020).
Autor:
Dubucs C; Department of Cytology and Pathology, Toulouse Cancer University Institute, CHU Toulouse, CEDEX, 31059 Toulouse, France.; Rangueil Faculty of Medicine, Paul Sabatier University, Toulouse-3, CEDEX, 31062 Toulouse, France., Basset C; Department of Cytology and Pathology, Toulouse Cancer University Institute, CHU Toulouse, CEDEX, 31059 Toulouse, France.; Rangueil Faculty of Medicine, Paul Sabatier University, Toulouse-3, CEDEX, 31062 Toulouse, France.; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31062 Toulouse, France., D'Aure D; Department of Cytology and Pathology, Toulouse Cancer University Institute, CHU Toulouse, CEDEX, 31059 Toulouse, France., Courtade-Saïdi M; Department of Cytology and Pathology, Toulouse Cancer University Institute, CHU Toulouse, CEDEX, 31059 Toulouse, France.; Rangueil Faculty of Medicine, Paul Sabatier University, Toulouse-3, CEDEX, 31062 Toulouse, France.; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31062 Toulouse, France., Evrard SM; Department of Cytology and Pathology, Toulouse Cancer University Institute, CHU Toulouse, CEDEX, 31059 Toulouse, France.; Rangueil Faculty of Medicine, Paul Sabatier University, Toulouse-3, CEDEX, 31062 Toulouse, France.; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31062 Toulouse, France.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Dec 01; Vol. 11 (12). Date of Electronic Publication: 2019 Dec 01.
Autor:
Evrard SM; Pathology and Cytology Department, Toulouse University Hospital (CHU), Toulouse Cancer University Institute (IUCT) Oncopole, Toulouse, France; Histology and Embryology Department, Rangueil Medical School, Toulouse III Paul Sabatier University, Toulouse, France. Electronic address: solene.evrard@univ-tlse3.fr., Taranchon-Clermont E; Pathology and Cytology Department, Toulouse University Hospital (CHU), Toulouse Cancer University Institute (IUCT) Oncopole, Toulouse, France., Rouquette I; Pathology and Cytology Department, Toulouse University Hospital (CHU), Toulouse Cancer University Institute (IUCT) Oncopole, Toulouse, France., Murray S; BioPath Innovations S.A., Athens, Greece; BioMarker Solutions Limited, London, United Kingdom., Dintner S; Institute of Pathology, Klinikum Augsburg, Augsburg, Germany., Nam-Apostolopoulos YC; Institute of Pathology, Klinikum Augsburg, Augsburg, Germany., Bellosillo B; Laboratori de Diagnòstic Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain., Varela-Rodriguez M; Pathology Department, Hospital Universitari de Bellvitge, Hospitalet, Barcelona, Spain., Nadal E; Department of Medical Oncology, Catalan Institute of Oncology, Hospitalet, Barcelona, Spain; Clinical Research in Solid Tumors (CReST) Group, Oncobell Program, The Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet, Barcelona, Spain., Wiedorn KH; Molecular Pathology Department, Medizinisches Versorgungszentrum (MVZ) Zentrum für Pathologie und Zytodiagnostik GmbH (ZPZ) Köln, Cologne, Germany., Melchior L; Department of Pathology, Rigshospitalet, Copenhagen, Denmark., Andrew E; Molecular Cell Pathology Unit, Histopathology, Royal Cornwall Hospital, Cornwall, United Kingdom., Jones M; Molecular Cell Pathology Unit, Histopathology, Royal Cornwall Hospital, Cornwall, United Kingdom., Ridgway J; Molecular Pathology Department, ACT Pathology, Canberra Hospital, Garran, Australian Capital Territory, Australia., Frykman C; Clinical Pathology and Cytology Department, Laboratoriemedicin Gävle, Gävleborg, Sweden., Lind L; Clinical Pathology and Cytology Department, Laboratoriemedicin Gävle, Gävleborg, Sweden., Rot M; Laboratory for Cytology and Pathology, University Clinic for Respiratory and Allergic Diseases Golnik, Golnik, Slovenia., Kern I; Laboratory for Cytology and Pathology, University Clinic for Respiratory and Allergic Diseases Golnik, Golnik, Slovenia., Speel EJM; Department of Pathology, GROW-School for Oncology and Developmental Biology Department, Maastricht UMC+, Maastricht, the Netherlands., Roemen GMJM; Department of Pathology, GROW-School for Oncology and Developmental Biology Department, Maastricht UMC+, Maastricht, the Netherlands., Trincheri N; Department of Pathology, Humanitas Research Hospital, Milan, Italy., Freiberger SN; Department of Pathology and Molecular Pathology, Diagnostic Tumor Genome Analysis University Hospital Zurich, Zurich, Switzerland., Rechsteiner M; Department of Pathology and Molecular Pathology, Diagnostic Tumor Genome Analysis University Hospital Zurich, Zurich, Switzerland.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2019 Nov; Vol. 21 (6), pp. 1010-1024. Date of Electronic Publication: 2019 Aug 22.
Autor:
Deshors P; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France., Toulas C; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France.; Institut Claudius Regaud, IUCT-O, Toulouse, F-31059, France., Arnauduc F; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France.; University of Toulouse III Paul Sabatier, Toulouse, France., Malric L; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France., Siegfried A; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France.; University of Toulouse III Paul Sabatier, Toulouse, France.; Pathology and Cytology Department, Toulouse CHU, IUCT Oncopole, Toulouse, France., Nicaise Y; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France.; University of Toulouse III Paul Sabatier, Toulouse, France., Lemarié A; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France.; Faculty of Pharmaceutical Sciences, University of Toulouse III Paul Sabatier, Toulouse, France., Larrieu D; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France., Tosolini M; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France., Cohen-Jonathan Moyal E; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France.; Institut Claudius Regaud, IUCT-O, Toulouse, F-31059, France.; University of Toulouse III Paul Sabatier, Toulouse, France., Courtade-Saidi M; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France.; University of Toulouse III Paul Sabatier, Toulouse, France.; Pathology and Cytology Department, Toulouse CHU, IUCT Oncopole, Toulouse, France., Evrard SM; INSERM UMR 1037, Toulouse Cancer Research Center, Toulouse, France. solene.evrard@univ-tlse3.fr.; University of Toulouse III Paul Sabatier, Toulouse, France. solene.evrard@univ-tlse3.fr.; Pathology and Cytology Department, Toulouse CHU, IUCT Oncopole, Toulouse, France. solene.evrard@univ-tlse3.fr.
Publikováno v:
Cell death & disease [Cell Death Dis] 2019 Oct 28; Vol. 10 (11), pp. 816. Date of Electronic Publication: 2019 Oct 28.
Autor:
Escudié F; Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU Toulouse, France., Van Goethem C; Department of Pathology and Oncobiology, Laboratoire de biologie des tumeurs solides, CHU de Montpellier, Univ. Montpellier, France., Grand D; Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU Toulouse, France., Vendrell J; Department of Pathology and Oncobiology, Laboratoire de biologie des tumeurs solides, CHU de Montpellier, Univ. Montpellier, France., Vigier A; Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU Toulouse, France., Brousset P; Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU Toulouse, France., Evrard SM; Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU Toulouse, France., Solassol J; Department of Pathology and Oncobiology, Laboratoire de biologie des tumeurs solides, CHU de Montpellier, Univ. Montpellier, France., Selves J; Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU Toulouse, France.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2019 Oct 24. Date of Electronic Publication: 2019 Oct 24.